|
"huang yh"的相关文件
顯示項目 1-10 / 208 (共21頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-08-18 |
Enhancing radiosensitivity of boron neutron capture therapy for liver cancer with homologous recombination repair inhibitor
|
Lai, ZY;Huang, YH;Zhou, TY;Lee, CY;Shiao, YM;Chen, YW;Chou, FI;Chen, JK;Chuang, YJ |
| 國家衛生研究院 |
2025-08-18 |
Association between endocrine disruptors and depressive symptoms among taiwanese adolescents
|
Huang, YH;Huang, HC;Luo, TH;Wu, CH;Chen, HL;Hsueh, YC;Liu, S;Wang, SL |
| 國家衛生研究院 |
2025-08-06 |
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019
|
Kee, KM;Chen, CH;Liu, TW;Huang, YH;Hu, JT;Chau, GY;Chen, KH;Chiang, CJ;Lin, CC;Hung, CF;Wang, TE;Huang, SF;Ku, HY;Huang, BS;Ch'ang, HJ;Tseng, HP;Lu, SN |
| 國家衛生研究院 |
2025-08 |
Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes
|
Yen, FS;Wei, JCC;Huang, YH;Li, PY;Tsai, FJ;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2025-07-22 |
Sodium-glucose cotransporter 2 inhibitors use in patients with liver cirrhosis
|
Yen, FS;Hou, MC;Wei, JCC;Huang, YH;Shih, YH;Pan, CW;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-07-18 |
Chromoblastomycosis in Northern Taiwan from 2017 to 2024: Unique Characteristics
|
Yen, JS;Shih, IH;Chung, WH;Cheng, CY;Ng, CY;Chen, CB;Huang, YH;Sun, PL |
| 國家衛生研究院 |
2025-06-02 |
Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: A nationwide cohort study
|
Yen, FS;Wei, JCC;Ko, FS;Huang, YH;Yip, HT;Tsai, FJ;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-06 |
SGLT-2 inhibitors and the risk of chronic obstructive pulmonary disease exacerbations and mortality in chronic obstructive pulmonary disease patients
|
Yen, FS;Wei, JCC;Huang, YH;Hsu, TJ;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-05-23 |
Sedative-hypnotics are associated with additional risk of suicide in older adults: A population-based case-control study
|
Yang, HJ;Huang, YH;Cheng, WJ |
| 國家衛生研究院 |
2025-05 |
Sodium-glucose cotransporter2 inhibitors and associated liver-related outcomes in diabetes patients
|
Yen, FS;Wei, JCC;Wang, C;Hou, MC;Yu, TS;Huang, YH;Hwu, CM;Hsu, CC |
顯示項目 1-10 / 208 (共21頁)
1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
